Thomas Klabunde

Affiliations
  • R&D Data & Data Science, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.

Publications (4)

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide.

Diabetes, obesity & metabolism
Avec: Michele Schiavon , Roberto Visentin , Britta Göbel , Michela Riz , Claudio Cobelli , Thomas Klabunde , Chiara Dalla Man

Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes.

Diabetes, obesity & metabolism
Avec: Roberto Visentin , Michele Schiavon , Britta Göbel , Michela Riz , Claudio Cobelli , Thomas Klabunde , Chiara Dalla Man

Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.

IEEE transactions on bio-medical engineering
Avec: Roberto Visentin , Michele Schiavon , Clemens Giegerich , Thomas Klabunde , Chiara Dalla Man , Claudio Cobelli

Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes.

IEEE transactions on bio-medical engineering
Avec: Michele Schiavon , Roberto Visentin , Clemens Giegerich , Thomas Klabunde , Claudio Cobelli , Chiara Dalla Man

Réseau de co-auteurs

Michele Schiavon 4 collaborations
Roberto Visentin 4 collaborations
Claudio Cobelli 4 collaborations
Chiara Dalla Man 4 collaborations
Britta Göbel 2 collaborations
Michela Riz 2 collaborations
Clemens Giegerich 2 collaborations